Table 4.
Results of the cost-effectiveness analysis.
| Conventional OR | LF-iMR | Incremental (iMR – Conventional OR) | ||
|---|---|---|---|---|
| Cost | (€ 2018) | 11,599 | 10,810 | 789 |
| Effectiveness measures | Postoperative KPS | 77.1 | 84.3 | 7.1 |
| R-KPS | 35 | 52 | 17 | |
| 1-year PFS | 295 | 333 | 38 | |
| ICER | Postoperative KPS | n.a. | n.a. | 111 |
| R- KPS | n.a. | n.a. | 46 | |
| 1-year PFS | n.a. | n.a. | 21 |
ICER, Incremental cost-effectiveness ratio: cost per additional unit of effectiveness (per additional point of postoperative KPS, percentage point of R-KPS or days of PFS); KPS, Karnofsky performance status; n.a., not-applicable; PFS, Progression-free survival; R-KPS, Resection and postoperative KPS.